phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Opioid-Related Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allard, M; Gold, L; Simonnet, G; Stinus, L | 1 |
| Cadet, JL; Emilien, B; Goodman, CB; Heyliger, S; Lee, CH; Partilla, JS; Rothman, RB; Yang, HY | 1 |
| Dougherty, TM; Fowler, DE; Hammond, MV; Lake, JR; Leyva, JE; Ludgate, K; Malin, DH; Rogillio, RB; Sloan, JB | 1 |
1 review(s) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Opioid-Related Disorders
| Article | Year |
|---|---|
FMRF-NH2 like mammalian octapeptide in opiate dependence and withdrawal.
Topics: Animals; FMRFamide; Humans; Neuropeptides; Neurotransmitter Agents; Oligopeptides; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1990 |
2 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Opioid-Related Disorders
| Article | Year |
|---|---|
Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment.
Topics: Adaptation, Biological; Animals; Central Nervous System; Drug Tolerance; Models, Biological; Morphine; Naloxone; Neuropeptides; Oligopeptides; Opioid-Related Disorders; Pain Threshold; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1995 |
Chronic exposure to antibodies directed against anti-opiate peptides alter delta-opioid receptor levels.
Topics: alpha-MSH; Animals; Antibodies; Autoradiography; Brain; Dynorphins; Male; Narcotic Antagonists; Oligopeptides; Opioid Peptides; Opioid-Related Disorders; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Tissue Distribution | 1999 |